Msr Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.73%
- Profit Growth 9.35%
- Ebitda 26.20%
- Net Worth 13.05%
- Total Assets 62.90%
About Msr Pharmaceuticals
Msr Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2014 and has a history of 11 years. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Manjeet Mishra, Ranbir Kumar, and Shweta Bharti serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120BR2014PTC022014
- Company No.
022014
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Msr Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjeet Mishra  | Director | 08-Feb-2014 | Current |
| Ranbir Kumar | Director | 13-Apr-2022 | Current |
| Shweta Bharti | Director | 08-Feb-2014 | Current |
Financial Performance of Msr Pharmaceuticals.
Msr Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.73% increase. The company also saw a slight improvement in profitability, with a 9.35% increase in profit. The company's net worth Soared by an impressive increase of 13.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msr Pharmaceuticals?
In 2021, Msr Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivakam Healthcare Private LimitedManjeet Mishra is a mutual person
- Aahana Developers And Buildings Private Limited
Manjeet Mishra and Shweta Bharti are mutual person
- Eurokem Pharmaceuticals Private Limited
Ranbir Kumar and Shweta Bharti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Msr Pharmaceuticals?
Unlock and access historical data on people associated with Msr Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msr Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msr Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
